Cargando…

The association between DNA methylation of 6p21.33 and AHRR in blood and coronary heart disease in Chinese population

BACKGROUND: Early detection could significantly improve the prognosis of coronary heart disease (CHD). In-invitro diagnostic technique may provide a solution when sufficient biomarkers could be identified. Pertinent associations between blood-based aberrant DNA methylation and smoking, the pathogene...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Liya, Zhu, Chao, Wang, Jinxin, Yang, Rongxi, Zhao, Xiaojing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375073/
https://www.ncbi.nlm.nih.gov/pubmed/35964014
http://dx.doi.org/10.1186/s12872-022-02766-8
_version_ 1784767881467133952
author Zhu, Liya
Zhu, Chao
Wang, Jinxin
Yang, Rongxi
Zhao, Xiaojing
author_facet Zhu, Liya
Zhu, Chao
Wang, Jinxin
Yang, Rongxi
Zhao, Xiaojing
author_sort Zhu, Liya
collection PubMed
description BACKGROUND: Early detection could significantly improve the prognosis of coronary heart disease (CHD). In-invitro diagnostic technique may provide a solution when sufficient biomarkers could be identified. Pertinent associations between blood-based aberrant DNA methylation and smoking, the pathogenesis of atherosclerosis, and CHD have been robustly demonstrated and replicated, but that studies in Chinese populations are rare. The blood-based methylation of aryl-hydrocarbon receptor repressor (AHRR) cg05575921 and 6p21.33 cg06126421 has been associated with cardiovascular mortality in Caucasians. Here, we aim to investigate whether the AHRR and 6p21.33 methylation in the blood is associated with CHD in the Chinese population. METHODS: In this case–control study, 180 CHD patients recruited at their first registration in our study center, and 184 controls randomly selected from the people who participated in the annual health examination were enrolled. Methylation intensities of 19 CpG sites, including AHRR cg05575921, 6p21.33 cg06126421, and their flanking CpG sites, were quantified by mass spectrometry. The association between methylation intensities and CHD was estimated by logistic regression analyses adjusted for covariant. RESULTS: Compared to the controls, lower methylation of 6p21.33_CpG_4.5/cg06126421 was independently associated with increased odds of being a CHD patient (OR per − 10% methylation = 1.42 after adjustment for age, gender, and batch effect; p = 0.032 by multiple testing corrections). No association between blood-based AHRR methylation and CHD was found. CONCLUSIONS: 6p21.33 methylation exhibits a significant association with CHD. The combination of 6p21.33 methylation and conventional risk factors might be an intermediate step towards the early detection of CHD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12872-022-02766-8.
format Online
Article
Text
id pubmed-9375073
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93750732022-08-14 The association between DNA methylation of 6p21.33 and AHRR in blood and coronary heart disease in Chinese population Zhu, Liya Zhu, Chao Wang, Jinxin Yang, Rongxi Zhao, Xiaojing BMC Cardiovasc Disord Research Article BACKGROUND: Early detection could significantly improve the prognosis of coronary heart disease (CHD). In-invitro diagnostic technique may provide a solution when sufficient biomarkers could be identified. Pertinent associations between blood-based aberrant DNA methylation and smoking, the pathogenesis of atherosclerosis, and CHD have been robustly demonstrated and replicated, but that studies in Chinese populations are rare. The blood-based methylation of aryl-hydrocarbon receptor repressor (AHRR) cg05575921 and 6p21.33 cg06126421 has been associated with cardiovascular mortality in Caucasians. Here, we aim to investigate whether the AHRR and 6p21.33 methylation in the blood is associated with CHD in the Chinese population. METHODS: In this case–control study, 180 CHD patients recruited at their first registration in our study center, and 184 controls randomly selected from the people who participated in the annual health examination were enrolled. Methylation intensities of 19 CpG sites, including AHRR cg05575921, 6p21.33 cg06126421, and their flanking CpG sites, were quantified by mass spectrometry. The association between methylation intensities and CHD was estimated by logistic regression analyses adjusted for covariant. RESULTS: Compared to the controls, lower methylation of 6p21.33_CpG_4.5/cg06126421 was independently associated with increased odds of being a CHD patient (OR per − 10% methylation = 1.42 after adjustment for age, gender, and batch effect; p = 0.032 by multiple testing corrections). No association between blood-based AHRR methylation and CHD was found. CONCLUSIONS: 6p21.33 methylation exhibits a significant association with CHD. The combination of 6p21.33 methylation and conventional risk factors might be an intermediate step towards the early detection of CHD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12872-022-02766-8. BioMed Central 2022-08-13 /pmc/articles/PMC9375073/ /pubmed/35964014 http://dx.doi.org/10.1186/s12872-022-02766-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Zhu, Liya
Zhu, Chao
Wang, Jinxin
Yang, Rongxi
Zhao, Xiaojing
The association between DNA methylation of 6p21.33 and AHRR in blood and coronary heart disease in Chinese population
title The association between DNA methylation of 6p21.33 and AHRR in blood and coronary heart disease in Chinese population
title_full The association between DNA methylation of 6p21.33 and AHRR in blood and coronary heart disease in Chinese population
title_fullStr The association between DNA methylation of 6p21.33 and AHRR in blood and coronary heart disease in Chinese population
title_full_unstemmed The association between DNA methylation of 6p21.33 and AHRR in blood and coronary heart disease in Chinese population
title_short The association between DNA methylation of 6p21.33 and AHRR in blood and coronary heart disease in Chinese population
title_sort association between dna methylation of 6p21.33 and ahrr in blood and coronary heart disease in chinese population
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375073/
https://www.ncbi.nlm.nih.gov/pubmed/35964014
http://dx.doi.org/10.1186/s12872-022-02766-8
work_keys_str_mv AT zhuliya theassociationbetweendnamethylationof6p2133andahrrinbloodandcoronaryheartdiseaseinchinesepopulation
AT zhuchao theassociationbetweendnamethylationof6p2133andahrrinbloodandcoronaryheartdiseaseinchinesepopulation
AT wangjinxin theassociationbetweendnamethylationof6p2133andahrrinbloodandcoronaryheartdiseaseinchinesepopulation
AT yangrongxi theassociationbetweendnamethylationof6p2133andahrrinbloodandcoronaryheartdiseaseinchinesepopulation
AT zhaoxiaojing theassociationbetweendnamethylationof6p2133andahrrinbloodandcoronaryheartdiseaseinchinesepopulation
AT zhuliya associationbetweendnamethylationof6p2133andahrrinbloodandcoronaryheartdiseaseinchinesepopulation
AT zhuchao associationbetweendnamethylationof6p2133andahrrinbloodandcoronaryheartdiseaseinchinesepopulation
AT wangjinxin associationbetweendnamethylationof6p2133andahrrinbloodandcoronaryheartdiseaseinchinesepopulation
AT yangrongxi associationbetweendnamethylationof6p2133andahrrinbloodandcoronaryheartdiseaseinchinesepopulation
AT zhaoxiaojing associationbetweendnamethylationof6p2133andahrrinbloodandcoronaryheartdiseaseinchinesepopulation